Drupal.behaviors.print = function(context) {window.print();window.close();}>
Amid Declining Revenues, Illumina Plans to Restructure, Focus on Clinical Market
October 25, 2011
Amid Declining Revenues, Illumina Plans to Restructure, Focus on Clinical Market
Full-text access for premium subscribers only.
Existing premium subscribers
login here
.
New to GenomeWeb?
Register here
quickly.
Related Stories
MiSeq, Consumables, Services Drive Illumina's Q4 Revenues as it Begins Work on Nanopore Sequencing
January 29, 2013 / In Sequence
Record Orders for MiSeq, Consumables Drive Illumina's Q1 Sequencing Revenues
April 24, 2012 / In Sequence
Illumina Sees Growing Commercial Customer Base; Doubled Clinical HiSeq Placements in 2011
February 8, 2012 / Clinical Sequencing News
Illumina Books Orders for More than 135 MiSeqs, Starts Early-Access Shipments
August 2, 2011 / In Sequence
NIPT and Cancer Drive Illumina's Clinical Business in Q1 as it Looks to Launch Fetal Aneuploidy IVD
April 24, 2013 / Clinical Sequencing News